Table 1. Demographic and clinical data of the individuals with 22q11Ds included in the study.
Individual | Age | Gender | Deletionsize | Type ofCHDa | Hypocalcemiab | Seizuresd | RenalAbnb | ThyroidAbnb | Left HPCVolume(mL)e | RightHPCVolume(mL)e | WholeBrainVolume(mL)f | HeadCircumference |
1 | 9 | F | 3 Mb | 0 | 2 | 0 | 0 | 0 | 1.63 | 1.88 | 1242.56 | 54.60 |
2 | 8 | M | 3 Mb | 0 | 0 | 2 | 0 | 2 | 1.32 | 1.43 | 1070.68 | 48.5 |
3 | 15 | M | 3 Mb | 0 | 0 | 0 | 0 | 0 | 1.75 | 1.97 | 1231.16 | 54.5 |
4 | 14 | M | 3 Mb | 0 | 0 | 0 | 0 | 0 | 1.6 | 1.67 | 1353.01 | 59 (N/A) |
5 | 8 | M | 3 Mb | 0 | 0 | 0 | 0 | 0 | 1.67 | 1.75 | 1294.11 | 52 |
6 | 10 | M | 3 Mb | TOF, VaR | 0 | 0 | N/Ac | 0 | 1.29 | 1.35 | 1089.06 | 51.75 (N/A) |
7 | 11 | F | 3 Mb | TA | 2 | 0 | 2 | 2 | 0.9 | 0.95 | 1006.1 | 49.5 |
8 | 9 | M | 3 Mb | VR | 0 | 0 | 0 | 0 | 1.47 | 1.63 | 1243.89 | 53 |
9 | 11 | M | 3 Mb | TOF, PA | 2 | 0 | 0 | 0 | N/A | N/A | 1188.26 | 52.07 |
10 | 15 | F | 3 Mb | TOF, VSD | 0 | 0 | 0 | 0 | 1.09 | 1.27 | 1084.95 | N/A |
11 | 12 | F | 3 Mb | VR, BAV | 2 | 0 | 0 | 0 | 1.56 | 1.5 | 1234.23 | 57 |
12 | 8 | M | 3 Mb | 0 | 0 | 0 | 0 | 0 | 1.41 | 1.27 | 1237.97 | 53.5 |
13 | 11 | M | 3 Mb | 0 | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 53.5 |
14 | 14 | M | 3 Mb | 0 | 2 | 0 | 0 | 2 | 1.35 | 1.54 | 1200.58 | 55.2 |
15 | 5 | M | 3 Mb | 0 | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 55.5 |
16 | 4 | F | 3 Mb | TA | 2 | 1 & 2 | 0 | 2 | N/A | N/A | N/A | 50.5 |
17 | 4 | F | 3 Mb | TA | 2 | 1 | 0 | 2 | N/A | N/A | 1108.88 | 50.5 |
18 | 11 | F | 3 Mb | VSD | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 51.5 |
19 | 11 | M | 3 Mb | 0 | 2 | 1 | 0 | 0 | N/A | N/A | 1432.14 | 57 |
20 | 6 | M | 3 Mb | ASD/VSD | 0 | 0 | 0 | 0 | N/A | N/A | 1214.46 | 51.5 |
21 | 8 | M | 3 Mb | VR | 0 | 2 | 2 | 0 | N/A | N/A | N/A | 56 |
22 | 8 | M | 3 Mb | 0 | 0 | 0 | 2 | 0 | N/A | N/A | N/A | 52.5 |
23 | 8 | M | 3 Mb | TOF | 2 | 0 | 0 | 0 | N/A | N/A | N/A | 54.6 |
24 | 11 | F | 3 Mb | PDA, ASD/VSD, PFO | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 53.5 |
25 | 5 | F | 3 Mb | TOF | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 52.07 |
26 | 4 | F | 3 Mb | 0 | N/Ac | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
27 | 5 | M | 3 Mb | 0 | 0 | 0 | N/A | N/A | N/A | N/A | N/A | 51 |
28 | 8 | M | 3 Mb | 0 | 0 | 0 | 0 | 0 | 1.54 | 1.66 | 1279.48 | 54.6 |
29 | 3 | F | 3 Mb | ASD/VSD | 0 | 0 | 0 | 0 | 1.21 | 1.61 | 9572.97 | 48.5 |
30 | 9 | M | 1.5 Mb | IAA, ASD/VSD, mild aortic stenosis | 2 | 1 & 2 | 0 | 0 | 1.78 | 1.91 | 1206.48 | 53 |
TOF = Tetralogy of Fallot; PA = Pulmonary Atresia; VSD = Ventricular Septal Defect; TA = Truncus Arteriosus; VR = Vascular Ring; BAV = Bicuspid Aortic Valve, VaR = Valve Replacement; ASD = Atrial Septal Defect; AAA = Aortic Arch Abnormalities; IAA = Interrupted aortic arch.
0 = No; 2 = Yes.
N/A = Data not available.
0 = No; 1 = Hypocalcemic seizures; 2 = Yes.
Average hippocampal volume for TD individuals is 2 mL.
Average whole brain volume for TD individuals is 1200 mL.
HPC = hippocampus.
Abn = abnormality.